Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

<< Previous

Bullboard Posts

Next >>

Post by LingMai2024on May 24, 2024 7:27am

102 Views

Post# 36055394

FSD Pharma Marketcap $14M with little to no debt

Recent market cap of only about $14 million w little to no debt. FSD Pharma only has just over 42 million shares outstanding with a recent market cap of about $14 million and over 6.5 million shares owned by insidersSignificant Insider purchases made over past three years at prices between ($U.S.).80 and $2.08 per share.

<< Previous

Bullboard Posts

Next >>

Aki Battery Recycling JV to capitalize on Ontario’s EV supply chain spot